$4.1 million funding supports epilepsy treatment research using spider venom proteins

UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.

Associations between cardiorespiratory fitness in young men and the incidence of site-specific cancer

A recent study assessed the association between cardiorespiratory fitness and some cancers in healthy young men.

August 21, 2023

Breakthrough MS drug uses green mamba venom discovery to promote myelin repair

Ten years of work, and a little help from the green mamba snake, has resulted in a promising new drug that is already being tested

August 5, 2024

Syncona buys gene therapy company; Oryzon’s €45M financing agreement; InDex scraps PhIII drug

Syncona scoops up Freeline: British life sciences investor Syncona said Wednesday it agreed to buy gene therapy maker Freeline Therapeutics through a new portfolio company.

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.